MXPA97005839A - Two level loading impulse apparatus to facilitate nerve localization during peripheral nerve blocking procedures - Google Patents

Two level loading impulse apparatus to facilitate nerve localization during peripheral nerve blocking procedures

Info

Publication number
MXPA97005839A
MXPA97005839A MXPA/A/1997/005839A MX9705839A MXPA97005839A MX PA97005839 A MXPA97005839 A MX PA97005839A MX 9705839 A MX9705839 A MX 9705839A MX PA97005839 A MXPA97005839 A MX PA97005839A
Authority
MX
Mexico
Prior art keywords
needle
electro
distal end
current
nerve
Prior art date
Application number
MXPA/A/1997/005839A
Other languages
Spanish (es)
Other versions
MX9705839A (en
Inventor
C Houghton Frederick
L Griffith Richard
J Strowe Robert
C Newell Jonathan
M Edic Peter
F Messina Ralph
Original Assignee
Becton Dickinson And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/695,151 external-priority patent/US5853373A/en
Application filed by Becton Dickinson And Company filed Critical Becton Dickinson And Company
Publication of MXPA97005839A publication Critical patent/MXPA97005839A/en
Publication of MX9705839A publication Critical patent/MX9705839A/en

Links

Abstract

An electrolocation device is provided to locate a nerve to which anesthesia can be delivered. The apparatus includes a needle assembly having a non-conductive tube with electrically conductive needle cannula secured through the needle cannula, and conductive galvanization in the tube. The conductors are connected with a stimulator that generates high and low alternative load impulses with a constant low current level. The high load impulses generate perceptible muscle jerks immediately after inserting the needle into the patient. The muscle jerks that respond to the high load impulses will reach the maximum in magnitude and the muscle jerks that respond to the low load impulses will become observable as the needle approaches the reference nerve and can not be distinguished from the jolts muscles that respond to high load impulses when the needle is in a position for anesthetic administration

Description

"LOADING IMPULSE TO TWO LEVELS TO FACILITATE THE LOCALIZATION OF THE NERVE DURING THE PROCEDURES OF BLOCKING OF THE PERIPHERAL NERVE " BACKGROUND OF THE INVENTION 1. Field of Invention The present invention relates to an apparatus for efficiently locating a nerve and subsequently supplying an anesthetic to the nerve. 2. Description of the Prior Art. Many medical procedures require that a patient be at least locally anesthetized. A regional anesthesia or nerve block offers advantages in relation to general anesthesia for many medical procedures. For example, a regional anesthesia or nerve block is typically less traumatic for a patient undergoing surgery, and often allows a shorter post-operative recovery. A regional anesthesia or nerve block necessarily requires the location of the nerve to which the anesthetic agent must be administered. The prior art includes methods for locating the nerve. In most methods of the prior art, the doctor typically uses his general knowledge of physical anatomy to locate approximately the reference nerve. In accordance with a method of the prior art, an electrically conductive pad is placed on the skin in a portion of the patient's body at a distance from the reference nerve. For example, if the reference ridge is in the shoulder, the electrically conductive pad can be secured at a distant portion of the arm. The electrically conductive pad is connected by a wire with a stimulator box of the prior art which is capable of generating an electric current, as will be further explained herein. An electrically isolated needle cannula with a non-isolated conductive tip is then pushed through the skin and subcutaneous tissue in the general direction of the nerve to be anesthetized. The needle of the prior art is connected by a wire with an electrical stimulator box of the prior art. The stimulator box of the prior art is electrically energized and operates to produce an adjustable current pulse over a duration of about 100 to 200 microseconds ("uS"). The current pulse is initially graduated to a level of approximately 1.0 to 5.0 iliampers ("mA"). This level of current is typically sufficient to stimulate the reference nerve when the needle has been placed within the tissue in the approximate area of the reference nerve. The stimulus will cause a perceptible muscular shock in the areas of the body controlled by the reference nerve (eg, the fingers). The current is then slowly discharged until the shaking disappears. The needle of the prior art is then advanced slowly towards the reference nerve until the shaking reappears. This iterative procedure continues until the needle of the prior art is capable of generating perceptible muscle shocks at a current level of about 0.2 to 0.3 milliamper. At this point, the needle of the prior art is considered to be close enough to the reference nerve for administration of the anesthetic agent. The anesthetic agent is then delivered directly through the needle, while the needle continues to produce current pulses. The cessation of muscle shaking is typically considered to indicate satisfactory nerve localization. The electrolocation method of the prior art is intended to ensure the exact placement of a needle for the anesthetic delivery. However, the prior art device and the prior art method for electrolocation of a reference nerve have several drawbacks. For example, the electrolocation device of the prior art including the stimulator box, is a rather large, expensive and reusable piece of equipment that is not easily sterilized. Therefore, there are problems using the prior art electro location device in the sterile environment of an operating room. Typically it is necessary to employ two technicians to carry out this prior art method, namely, a first technician operating under sterile conditions and having the needle manipulated, and a second technician separated from the first technician and operating under non-sterile conditions. to decrease the level of the current incrementally. The use of two technicians necessarily requires rather high costs and requires considerable coordination and communication between the two technicians. Second, the electrolocation device of the prior art does not provide a definitive indication of when the needle has been properly positioned to inject the anesthetic. The attending physician must depend on his judgment and experience to determine when the needle is in the optimal position. Third, the considerable distance between the isolated needle and the conductive pad of the prior art requires the generation of a relatively high voltage to achieve the level of the desired current. A voltage of at least 25 volts ("V") is common in the electrolocation apparatus of the prior art. These relatively high voltage levels limit the use of the prior art apparatus. For example, high voltage levels can affect the operation of spacers and other implanted electronic devices. In this way, the electrolocalization device of the technique, in general, can not be used in patients with implanted electronics. In addition, relatively high energy creates the risk of arcing. Therefore, the electro-localization apparatus of the prior art can not be used in many surgical environments, such as those where oxygen is being used, due to the risk of fire or explosion. High current levels can also create the potential for tissue damage in proximity to the needle.
COMPENDIUM OF THE INVENTION The present invention is directed to an electro-localization apparatus for accurately and efficiently locating a nerve to which an anesthetic agent can be administered. The apparatus employs energy levels low enough to avoid potential tissue damage and to allow use of the apparatus in situations where a patient has an implanted electronic device. The apparatus is also small and economical enough to be manufactured for single use and can be made sterile enough to be used in the sterile field of an operating room. In addition, the device can be used by only one technician. As mentioned above, the voltage required for the electrolocation apparatus is a function of the distance between two conductors and the resistance to contact with the patient. To minimize the distance considerably, the present invention provides both conductors in the needle cannula. More particularly, the electro-location apparatus of the present invention can employ a needle assembly having a pair of conductors coaxially positioned. An internal conductor of the pair of coaxial conductors can be defined by the needle. The non-conductive liner or tube can then be mounted above the inner conductor and can be galvanized, coated, co-extruded or otherwise provided with an electrically conductive material that functions as the external conduit. A chamfer or chamfer can be defined at the distal end of the non-conductive tube. The bevel can be defined by a non-conductive adhesive at the distal end of the tube. The beveled adhesive works to hold the tube in place and also facilitates the entry of the needle assembly into the patient. The spacing between the conductors of the electrolocation device is defined by the distance from the distant edge of the bevel to the conductive liner, which is preferably lighter than 1.0 millimeter ("mm"). In view of this very small distance, a very low voltage can be used to generate the required current. It is believed by the present inventors that this aspect of the invention makes the present electro-localization apparatus suitable for use with patients having implanted electronic devices, such as spacers. In addition, the low energy level allows the present electro-localization apparatus to be used eventually in all environments of the operating rooms, including those where the prior art electrolocation apparatus has created the combustion potential. In addition, the low voltage allows a simple electronic circuit to be conveniently provided in a small package. As mentioned above, the prior art electrolocation device has required two technicians, namely a first technician to have the needle handled carefully, and a second technician to carefully vary the level of the current. The present electro-localization apparatus employs entirely a different structure that operates under entirely different principles and allows the use of an electro-localization device present by a single technician. The electrolocation device takes advantage of the determination that the threshold electrical parameter for generating a muscle jerk is measured more accurately in terms of the electric charge instead of the electric current. The electric charge is the product of current and time and the charge can be varied by changing either the current level or the duration of time. In a first preferred embodiment, the present electro-localization apparatus generates constant current pulses; however, the pulses in sequence alternate between a relatively long duration and a relatively short duration. In this way, the constant current pulses in sequence alternate between the relatively high load and a relatively low load. In a second modality, the electro-localization apparatus functions to alternatively supply relatively high current pulses (eg, 0.5 ph) to relatively low current pulses (eg, 0.1 to 0.2 mA). Each pulse can be of the same duration (eg, 0.1 to 0.2 millisecond ("S")) and the pulses can be generated at uniform intervals (eg, from 0.25 to 2.0 seconds). An approach for using the electro-localization device of the present invention may include pushing the needle toward the patient and toward the reference nerve. Relatively high charge impulses will generate muscle jerks at a distant site of the nerve after having penetrated the skin (e.g., when the tip of the needle is at a distance of approximately 1.0 centimeter from the reference nerve). The relatively low charge impulses, however, will not produce a sufficient load to generate muscle jerks at this initial distance. The pulses can be separated, for example, by approximately half a second (then "1/2" or "0.5" second (s)). Therefore, the doctor will initially observe the muscle jerks at intervals of approximately one second, coinciding with the high load impulses. As the needle moves toward the reference nerve, the physician may see a slight increase in the magnitude of the muscle jerks observed initially caused by the high load impulses. Simultaneously, the doctor will begin to observe small muscle jerks in response to the impulse of low load - lo ¬ which follows each high load impulse. In this way, using the example above, the physician will observe a large jolt in response to a high load impulse followed by 0.5 second later by a smaller jolt in response to a low load impulse followed then 0.5 second later by another jolt larger in response to a high load impulse. The jerks generated in response to the high load impulses will quickly reach the maximum such that further movement of the needle towards the reference nerve will not synificantly increase the magnitude or seriousness of the resultant jerks of the high load impulses. The jerks generated in response to low load impulses will gradually increase in magnitude and intensity as the needle continues to approach the reference nerve. These changes in the magnitude and intensity of the shakes of low load will be easily observable by the doctor who inserts the needle. As the tip of the needle approaches the reference nerve, the major and small shakes will become essentially indistinguishable, and the physician will only observe essentially identical muscle jerks at intervals of approximately 0.5 second or twice the interval initially observed. This will indicate to the physician that the needle tip is properly placed for the administration of the specified anesthetic. The anesthetic agent can then be pushed through the needle and into the reference nerve. The anesthetized nerve will then stop shaking, thus providing the physician with a clear indication that the reference nerve has been reached and that the anesthetic has made the intended effect. The physician can then simply activate a switch on the small control of the electro-localization device to terminate the flow of current to the needle. Although the present has been described primarily with the concept of generating alternative charge pulses in high and low sequence of sequences, it will be appreciated by one skilled in the art that the construction of the electrolocation device and the components described herein can be configured to produce a pattern. of repetition of graduated load impulses depending on the desired application. For example, depending on the anatomy of the region surrounding the nerve being sought, it can be shown beneficial to have a repetition pattern of gradual decrease in the charge impulse as it approaches the nerve instead of an alternate series of pulses of high level and low absolute load as it approaches the rib, ie the apparatus and the associated components can be configured in such a way that instead of supplying an alternative series of high and low level load pulses, it will supply a pattern of repetition of graduated load impulses with the graduation in each pattern declining from a load impulse to the selected maximum level up to a selected minimum level load impulse. In this way, for certain anatomies, the physician is provided with a larger scale of clinical observations regarding the nerve reaction, the load impulses, thus providing a more accurate knowledge for the physician of the location of the apparatus with respect to to the nerve. Other patterns are also possible.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a perspective view of a bipolar electro-localization apparatus in accordance with the present invention. Figure 2 is a cross-sectional view of a needle in accordance with the present invention. Figure 3 is a functional diagram of a set of circuit components whose function is to produce appropriate load pulses through the needle of Figure 2, in accordance with the present invention.
Figure 4 illustrates an example of a combination of the operating circuit components within the blocks of Figure 3. Figure 5 is a graph showing a pulse generation pattern according to the present invention.
DETAILED DESCRIPTION OF THE PREFERRED MODALITY An electrolocation apparatus in accordance with the present invention is generally identified by the number 10 of Figure 1. The apparatus 10 includes a needle assembly 12, a stimulator 14 and a tube 16 for delivering a dose of the anesthetic through the assembly 12. of needle The needle assembly 12, as shown more clearly in Figure 2, includes an elongated needle cannula 20 having opposite and distant ends 22 and 24 and a lumen 26 extending continuously therebetween. The needle cannula 20 is formed of an electrically conductive material and preferably of stainless steel. The proximal proportions of the needle cannula 20 are mounted securely on the stimulator 14 with the proximal and distal ends of the needle cannula 20 remaining on opposite sides of the stimulator 14. The distal end 24 of the needle cannula 20 is bevelled to a point that facilitates the perforation of the tissue to have access to the reference nerve. The needle assembly 12 further includes a thin-walled tube 28 positioned coaxially above the cannula 20 of the needle. The tube 28 has opposed and proximal ends 30 and 32 respectively and is formed of a non-conductive material such as polyimide. The proximal end 30 of the tube 28 is placed in the stimulator 14 as further explained herein. The distal end 32 of the tube 28 is approximately spaced from the beveled distal end 24 of the needle cannula 20. The tube 28 is dimensioned to be tightly coupled against the outer cylindrical surface of the cannula 20 of the needle. However, secure retention of the tube 28 in the cannula 20 of the needle is achieved by non-conductive epoxy 34 or other adhesive extending between the distal end 32 of the plastic tube 28 and the outer cylindrical surface of the needle cannula 20 . Epoxy 34 is chamfered to facilitate entry of needle assembly 12 into a patient. The chamfering preferably defines a length of approximately 1.0 millimeter. The tube 28 includes a conductive layer 36 on its external cylindrical surface which can be applied by electroplating or coating. The layer 36 is preferably gold and extends continuously from the proximal end 30 to the distal end 32 of the tube 28, to a thickness of approximately 550 angstroms. The needle assembly 12 functions effectively as a pair of coaxial conductors as explained hereinabove. In particular, the stainless steel needle cannula 20 functions as an internal conductor, while the gold layer 36 in the tube 28 functions as an external conductor. The tube 28 defines a non-conductive insulating material that separates the inner and outer conductors defined respectively by the stainless steel needle cannula 20 and the gold layer 36. As mentioned above, the stainless steel needle cannula 12 extends continuously through the stimulator 14 such that the proximal end 22 of the needle cannula is placed on one side of the stimulator 14, while the distant end 24 is Place on the opposite side of it. The proximal end 30 of the plastic tube 28 is placed inside the stimulator 14. As a result, both the stainless steel needle cannula 12 and the gold layer 36 are exposed for electrical contact within the stimulator 14. The stimulator 14 includes a housing 38 generally rectangular which may have length and width dimensions, for example, of about 19.84 millimeters and a thickness dimension, for example, of about 9.57 millimeters. The housing 38 can be formed of two halves 40 and 42 of the molded thermoplastic housing which are welded or adhered to one another. The upper and lower walls respectively may include concave regions to facilitate holding by the digits of the hand. The accommodation 38 carries out multiple functions, including providing structural support for the needle assembly 12, providing a convenient hold for handling the needle assembly 12 and secure closing of the electronic components of the electro-location apparatus 10. The electronic circuit of the stimulator 14 includes an on / off switch 48 and a light-emitting diode (LED) 50 both of which are accessible and / or visible from the outside of the housing 38. The on / off switch 48 operates to completing the circuit between a battery and other portions of the circuit, as will be described further below, and optionally to allow switching between high and low load levels, the LED 50 operates to generate a light pulse with each energy pulse electrical so that the technician or attending physician can compare the energy impulses with the muscular jerks in the patient. Figure 3 is representative of a circuit that can be used in simulator 14. As will be appreciated by an expert, one way to implement this circuit is to digitize it using CMOS technology as active elements. Other implementations, such as customary integrated circuits ("ICs") are also possible. Here, the on / off switch 48 is connected to a 3 volt lithium cell battery 52. In the disconnected state, the quiescent current is less than 1 icroamper ("uA") providing a battery life in excess of eight years, and thus ensuring adequate shelf life for the electrolocation apparatus 10. In the connected state, the oscillator and counter described below are capacitated and the battery will operate the stimulator 14 for approximately 100 hours. The modulation of the time duration pulse is achieved by a counter 54. Using the outputs of the counter 54 it is possible to generate a pulse as short as 122uS. Since the outputs of the counter 54 are periodic signals, the time selection gate network 56 selects only one period of the output signal and applies the same to the network 58 of the current source. In the embodiment shown in Figure 3, the network 56 may alternatively allow either a low charge pulse or a high charge impulse. As shown schematically in Figure 5, the stimulator 14 functions to alternatively generate pulses of short and long duration. All the impulses will be of a constant current but they will be of different durations. For example, stimulator 14 can operate to generate a pulse at a current level of 0.2mA for 122uS to produce a relatively low load of 24.4 nanocoulombs ("nC") followed by a current pulse of 0.2mA for approximately 488uS to produce a relatively high load of 97nC. It will be understood by a person skilled in the art that depending on the components selected to generate the pulses, the duration of the pulses may vary within a time scale, for example, of about +/- 20 percent of the durations that manifest themselves at the moment. Other pulses of constant current pairs for different durations can be used to produce low and high alternative loads. The circuit of Figure 3 is also designed to optionally provide constant education impulses with modulation of the amplitude of the current. For example, the 0.2mA low current pulse can be generated for 122uS to produce a relatively low load of 24.4nC and can be followed by a high current pulse of 0.8mA for 122uS in order to produce a relatively high load of 97nC . It will be noted that the loads produced by the option of the current level modulation are equal to the loads produced by the modulation option of time duration. Figure 3 is a functional diagram of a set of circuit components in the stimulator 14 that function to produce appropriate load pulses through the bipolar needle 12, and Figure 4 illustrates an example of a combination of operating circuit components within the blocks of Figure 3. As seen in Figure 3, an on / off control 51 operated by the switch 48 has an output that activates an oscillator 53 to activate the counter 54 and another output that capacites and incapacitates the counter 54. A third output is supplied to a control circuit 55 that receives an output from the counter 54 and activates a constant current sink 58 coupled with an electrode 20 or 36 of the bipolar 12 needle. The indicator circuit 57 that drives the LED 50 receives the inputs of the oscillator 53, the counter 54 and the current source V +, which through a load limiter 59 is coupled to another electrode (36 or 20) of the bipolar needle 12 . The time and magnitude of the charge pulses are modulated by a time selection gate component 56 which is coupled with the control circuit 55. Returning to the details of the circuit of Figure 4, the on / off control 51 may consist of the on / off switch 48 which couples the voltage V + of the battery 52 to a circuit including a vascular circuit A1B and an RC combination ( Rl, C3). When the apparatus 10 is to be used, the switch 48 is placed in the connected position and remains connected to avoid any of the abnormal transient currents in the needle. The tilting circuit A1B controls the time of the oscillator 53 which may comprise a Schimit A3A trip and capacitance and disable the counter 54 which may be in the form of a 12-bit counter A2 and the control circuit 55 sink, may comprise a vasculatory circuit A1A. When A and B is connected, the output line 12 is low or zero, so that the readjustment of the counter A2 is off and therefore, it is free to count, and the readjustment of A1A is disconnected so that it is free to change state. Concomitantly, the output line 13 of A1A is high or positive so that the oscillator A3A operates, v, gr, at 4,096 ilohertz ("kHz") to cause the counter A2 to count, after which the pin 1 of A2 is caused to change state every half second and pin 15 goes to the positive state every half second. In this way the pin 15 changes state to twice the speed of the pin 1. When A1B is disconnected, line 13 goes to the low state stopping the output of A3A and line 12 goes to the raised state by readjusting A2 and A1A. When the pin 15 of A2 goes to the positive state, the clock signal to the A1A causes the output line 1 to go to the high state by means of the voltage V +, supplying the base current to the transistor Q3, through the resistors R4 and R5. Q3 is caused in this way to drive by closing a current path so that current flows through needle 12 from battery V +, through capacitor C4 and through resistor R7 to ground. If the voltage in R7 goes to more than 0.55 V, the base of transistor Q2 will be driven through resistor R6 to connect Q2 which in turn decreases the base current to Q3, thereby maintaining the voltage across R7. at 0.55 V. Therefore, the current through the needle A2 remains essentially constant. In the event of a short circuit or failure of the needle current path, capacitor C4 acts to charge the limiter by charging to a preselected maximum load and limiting the current level.
The timing and shape of the current pulses is determined through the use of the time selection gate component 56 comprising three gates A3B, A3C and A3D which receive the inputs of the oscillator A3A and the counter A2 and provide an output to the Vascular circuit A1A of the dissipation control circuit 55. The gate A3B controls the short pulses shown in the timing diagram of Figure 5. It will be until the input pin 10 to the counter A2 works on the negative pulses so that when the output of A3A on the pin 3 goes to the state negative, the output pin of A2 goes to the positive state driving A1A to connect the current through the needle path as explained just above. The output on the pin 3 of A3A is also supplied to the input pin 6 of the gate A3B, the other input pin 5 from which the pin 1 of A2 receives the output. If the signal on the pin 1 and in turn on the pin 5 is raised, A3B can operate when the pin 6 goes towards the raised state. If pin 1 is low or zero, then pin 5 is low and A3B can not work. The operation of A3B can be used to control the alternation of short and long charge pulses. When pin 1 is in an elevated state, short pulses will occur.
More particularly, when the A3A pin 3 goes to the low state, the counter 54 will go to its next state. The pin 15 goes to the raised state so that the current begins to flow through the needle and the pin 1 goes to the raised state so that the pin 5 of A3B is in the raised state, while the pin 6 is in the raised state. low zero state together with pin 3. The output of A3B on pin 4 will be 1, it is the input on pin 13 to gate A3D. With an elevated entry in the pin 12, the output of the gate A3D in the pin 11 will be zero. Now, when the oscillator A3A sends a high state on the pin 3, the counter A2 does not change its state, but the pins 5 and 6 of A3B will both be in the raised state so that the output on the pin 4 will go to zero causing the entry to pin 13 to be zero. If the entry in the pin 12 is still raised, the output of A3D in the pin 11 goes towards the raised state. The high signal on the pin 11 is coupled through the capacitor C2 with the readjustment of the vascular circuit ALA causing its output on the pin 1 to go to zero, disconnecting the constant current dissipation 58 and the current through the needle 12. A short current pulse will then have to occur for a duration of 122uS.
To produce longer impulses, gate A3C is used and gate A3B becomes disabled. Since A3B can only function when the pin 1 of A2 is in the raised state, the signal on pin 1 is caused to go to the low state by disconnecting A3B. In this condition, the readjustment of the AlA function is controlled only by A3C. The output of A3C can be controlled according to the pulse ratio chart shown adjacent to A3C in Figure 4. By appropriately connecting the A (8) and B (9) inputs of A3C with the enumerated combination of pins of the counter A2, the time relationships between the short and prolonged pulses shown in the left-hand column of the frame can be achieved, thereby obtaining pulse width modulation of the load impulses. To achieve pulse amplitude modulation, inputs A and B to A3C can both connect to pin 10 of A2 to produce a pulse time ratio of 1 to 1, with pulses of 122 uS. An RIO resistor in the constant current dissipation 58 is connected in the circuit between the pin 1 of A2 and the emitter of the transistor Q3, closing a switch SW1. When pin 1 is in high condition, current flows through RIO and resistance R7 to ground. The current in the path of the current through the needle 12 therefore decreases since the voltage across R7 remains constant and the current through R7 is constituted by two sources. Consequently, the magnitude of the current pulse through the needle 12 becomes a comparatively low current pulse. When the pin 1 of A2 is in the low state, that is, it is going to ground, RIO is configured in parallel with R7 with respect to ground, so that the resistance through R7 and RIO decreases with respect to the current path . Since the 0.55V volt is maintained at its junction point, as explained above, a greater amount of current is needed through both resistors. Therefore, the magnitude of the current pulse through the needle 12 is increased resulting in a comparatively high current pulse. Therefore, pulse amplitude modulation can be achieved within this circuit. If desired, both pulse width modulation and pulse amplitude can be produced by selecting pulse ratios in the pulse ratio frame and switching the RIO resistor to the circuit. Finally, the indicator circuit 57 is configured to be activated when an impulse has occurred, independently of the modulation, and to produce a simple connection or disconnection indication. In this way, the LED 50 will turn on CONNECT NDOSE upon occurrence of a charging pulse or the buzzer 60 will produce a sound in accordance with the synchronization and change of state of the outputs on the pin 3 of A3A and the pin 15 of A2. As mentioned above, the proximal end 22 of the stainless steel needle cannula 20 projects entirely through the housing 38 of the stimulator 14. As shown in Figure 1, the proximal end 22 of the cannula 20 of The stainless steel needle is connected to a flexible pipe 16 which extends to a plug that is connectable with a syringe to deliver a selected dose of anesthetic. In an alternative embodiment, the proximal end 22 of the stainless steel needle cannula 20 can be mounted directly on a needle plug that is connectable with a syringe to deliver a selected dose of the anesthetic. During use, an anesthesiologist or nurse anesthetist inserts the beveled distant tip 24 of the stainless steel needle 20 in a patient and into the reference nerve. No wires or a conductive pad are used. In the constant current mode described herein, the switch 48 on the stimulator 14 is then operated to generate the constant low current pulses of electrical energy. The proper functioning of the electro-localization device 10 is confirmed by the turning on of the LED 50 which generates a light pulse or simultaneously with each respective energy pulse. The respective energy pulses are generated at 1/2 second intervals. The high load impulses of 0.2mA during 488uS will generate a load of 97nC. The low charge impulses are of the same current of 0.2mA, but they last only 122uS and will generate a charge of only 24.4nC. Higher load impulses of 97nC will be sufficient to generate observable muscle jerks in an essentially superficial location after the skin has been penetrated by gold layer 34, while lower loads, 24.4nC impulses will not be sufficient to generate initially no observable muscle jerks at this distance from the nerve. In this way, the anesthesiologist or nurse anesthetist will observe the muscular jerks at intervals of approximately one second coinciding with the high load impulses. The needle assembly 12 is pushed further towards the reference nerve. This advance of the needle assembly 12 will show a gradual increase in the magnitude of the jerks that occur at one second intervals. Nevertheless, these shakes in response to the high load will soon reach the maximum. The anesthesiologist or nurse will then observe muscle shaking of small magnitude between shakes of larger magnitude. Therefore, small and large alternative shakes of magnitude can easily be observed. As the needle assembly 12 is further advanced towards the patient, muscle shaking of small magnitude will increase in magnitude to approximate the magnitude of the maximal large magnitude muscle shaking generated by the high load impulses. At the distal tip 24 of the stainless steel needle cannula 20 near the reference nerve, the muscle jerks generated in response to the low load impulses will not be essentially distinguishable from the muscle jerks generated in response to the load energy impulses. elevated Therefore, the anesthesiologist or nurse will observe almost identical muscle jerks at 0.5 second intervals. This readily observable response will indicate to the anesthesiologist or nurse that the beveled distant tip of the needle cannula 20 is sufficiently close to the reference nerve for administration of the anesthetic. The anesthetic is supplied in the conventional manner by driving the hypodermic syringe communicating with the proximal end 22 of the stainless steel needle cannula 20. The exact procedure can be carried out by the alternative mode that modulates the level of the current. Although the invention has been described with respect to a preferred embodiment, it is clear that various changes can be made without departing from the scope of the invention as defined by the appended claims. For example, the stimulator may have switching mechanisms for changing the level of the current or the pulse width to vary the respective levels of the loads delivered to the patient. In addition, other impulse generation indications may be provided including an audible buzzer instead of or in addition to the LED described above.

Claims (16)

CLAIMS:
1. An integral electro-localization apparatus comprising: an electrically conductive needle cannula having a proximal end, a distal end and a hollow perforation therethrough; a non-conductive tube having a proximal end, a distal end and an open passage therethrough, the tube is mounted above the needle cannula so that the distal end of the non-conductive tube is close to the distal end of the needle cannula; a conductive layer having a distal end in the non-conductive tube whereby the needle cannula and the conductive layer respectively define first and second electrodes separated coaxially from one another by the non-conductive tube; a handle fixedly fixed to the needle cannula for manipulating the apparatus, the handle comprises a casing; and an electrical stimulus generating circuit within the envelope and electrically communicating with the first conductor and the second conductor, the stimulus generator being able to apply pre-selected loads to the conductors so that when the needle is placed in a tissue of the In the patient, the charges are sufficient to induce a preselected current between the distal end of the conductive layer and the distal end of the needle cannula through the patient's tissue, this current being sufficient to induce a shaking response in the patient. The apparatus according to claim 1, wherein the distance between the distal end of the cannula of the conductive needle and the distal end of the conductive layer is approximately 1.0 millimeter. 3. The electrolocation apparatus according to claim 1, wherein the electroconductive cannula projects proximal beyond the handle and includes a connector for connecting a drug delivery device to the perforation of the electroconductive needle. 4. The electro-location apparatus according to claim 3, wherein the connector further includes a flexible tube. The electro-localization apparatus according to claim 1, wherein the stimulus generating circuit includes an on / off switch accessible by the pressure of the physician's finger. 6. The electro-location location apparatus of claim 1, wherein the circuit provides the preselected load pulses in pre-selected repeatable patterns. 7. The electro-location apparatus according to claim 6, wherein the preselected patterns include different load current pulses. The electro-location apparatus according to claim 7, wherein the charge pulses are controlled by the circuit to comprise preselected constant currents. 9. The electro-location apparatus according to claim 8 wherein the preselected constant currents are between about 0.1 milliamper of about 0.8 milliamper. The electro-localization apparatus according to claim 6, wherein the preselected patterns include pulses of different durations. The electro-location apparatus according to claim 10, wherein the pulse durations are between about 100 microseconds and 1,000 microseconds. The electro-localization apparatus according to claim 6, wherein the preselected charge pulse pattern includes preselected time intervals between the pulses. The electro-localization apparatus according to claim 12, wherein the preselected time intervals are between about 0.25 second to about 2.0 seconds. 14. The electro-location apparatus according to claim 6, wherein the circuit further comprises an indication of the charge pulse. The electro-localization apparatus according to claim 14, wherein the indication further comprises an audible sound to the physician using that apparatus. The electro-localization apparatus according to claim 14, wherein the indication further comprises an emission of visible light to a physician using the apparatus.
MX9705839A 1996-08-05 1997-07-31 Bi-level charge pulse apparatus to facilitate nernerve location during peripheral nerve block procedures. MX9705839A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08695151 1996-08-05
US08/695,151 US5853373A (en) 1996-08-05 1996-08-05 Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures

Publications (2)

Publication Number Publication Date
MXPA97005839A true MXPA97005839A (en) 1998-02-01
MX9705839A MX9705839A (en) 1998-02-28

Family

ID=24791814

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9705839A MX9705839A (en) 1996-08-05 1997-07-31 Bi-level charge pulse apparatus to facilitate nernerve location during peripheral nerve block procedures.

Country Status (9)

Country Link
US (2) US5853373A (en)
EP (1) EP0823239A3 (en)
JP (1) JP3247856B2 (en)
KR (1) KR19980018336A (en)
AU (1) AU719246B2 (en)
BR (1) BR9704267A (en)
CA (1) CA2211752A1 (en)
MX (1) MX9705839A (en)
SG (1) SG50873A1 (en)

Families Citing this family (218)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853373A (en) * 1996-08-05 1998-12-29 Becton, Dickinson And Company Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US5993423A (en) * 1998-08-18 1999-11-30 Choi; Soo Bong Portable automatic syringe device and injection needle unit thereof
DE69927717T2 (en) 1998-12-23 2006-07-20 Nuvasive Inc., San Diego DEVICES FOR CANNULATION AND NERVE MONITORING
US6564078B1 (en) 1998-12-23 2003-05-13 Nuvasive, Inc. Nerve surveillance cannula systems
CA2363254C (en) 1999-03-07 2009-05-05 Discure Ltd. Method and apparatus for computerized surgery
US6298256B1 (en) * 1999-09-10 2001-10-02 Frank-Egbert Meyer Device and method for the location and catheterization of the surroundings of a nerve
US7470236B1 (en) * 1999-11-24 2008-12-30 Nuvasive, Inc. Electromyography system
US6466817B1 (en) 1999-11-24 2002-10-15 Nuvasive, Inc. Nerve proximity and status detection system and method
US6478769B1 (en) * 2000-02-22 2002-11-12 The Board Of Trustees Of The University Of Arkansas Anatomical fluid evacuation apparatus and method
US8611993B2 (en) * 2000-03-13 2013-12-17 Arrow International, Inc. Pre-loaded lockable stimulating catheter for delivery of anaesthetic drugs
US6456874B1 (en) * 2000-03-13 2002-09-24 Arrow International Inc. Instrument for delivery of anaesthetic drug
US7386341B2 (en) 2000-03-13 2008-06-10 Arrow International, Inc. Instrument and method for delivery of anaesthetic drugs
US6312392B1 (en) * 2000-04-06 2001-11-06 Garrett D. Herzon Bipolar handheld nerve locator and evaluator
EP1289415A4 (en) 2000-05-18 2008-12-03 Nuvasive Inc Tissue discrimination and applications in medical procedures
EP1292223A2 (en) * 2000-06-08 2003-03-19 Nuvasive, Inc. Relative nerve movement and status detection system and method
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
US6533732B1 (en) 2000-10-17 2003-03-18 William F. Urmey Nerve stimulator needle guidance system
DE10057832C1 (en) 2000-11-21 2002-02-21 Hartmann Paul Ag Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
JP2004522497A (en) * 2000-11-24 2004-07-29 シー ケー エム ダイアグノスティクス インコーポレーテッド Neurostimulator output control needle with depth determination function and method of using same
US20040034331A1 (en) * 2001-02-23 2004-02-19 Jason Toman Integrated medication delivery system
JP4058498B2 (en) * 2001-02-23 2008-03-12 ストライカー コーポレイション Integrated drug delivery system
DE20108558U1 (en) * 2001-05-22 2001-08-09 Krebs Peter Combination needle for the peripheral nerve blocks
US20030105503A1 (en) * 2001-06-08 2003-06-05 Nuvasive, Inc. Relative nerve movement and status detection system and method
EP1404234B1 (en) 2001-06-12 2011-02-09 Pelikan Technologies Inc. Apparatus for improving success rate of blood yield from a fingerstick
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
JP4272051B2 (en) 2001-06-12 2009-06-03 ペリカン テクノロジーズ インコーポレイテッド Blood sampling apparatus and method
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2002100460A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Electric lancet actuator
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US20030009111A1 (en) * 2001-06-13 2003-01-09 Cory Philip C. Non-invasive method and apparatus for tissue detection
JP4295086B2 (en) 2001-07-11 2009-07-15 ヌバシブ, インコーポレイテッド System and method for determining nerve proximity, nerve orientation, and pathology during surgery
EP1435828A4 (en) 2001-09-25 2009-11-11 Nuvasive Inc System and methods for performing surgical procedures and assessments
US6829508B2 (en) * 2001-10-19 2004-12-07 Alfred E. Mann Foundation For Scientific Research Electrically sensing and stimulating system for placement of a nerve stimulator or sensor
US7664544B2 (en) 2002-10-30 2010-02-16 Nuvasive, Inc. System and methods for performing percutaneous pedicle integrity assessments
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7481776B2 (en) 2002-04-19 2009-01-27 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8147421B2 (en) 2003-01-15 2012-04-03 Nuvasive, Inc. System and methods for determining nerve direction to a surgical instrument
US7582058B1 (en) 2002-06-26 2009-09-01 Nuvasive, Inc. Surgical access system and related methods
AU2003276857A1 (en) * 2002-09-04 2004-03-29 William F. Urmey Positioning system for a nerve stimulator needle
US8137284B2 (en) 2002-10-08 2012-03-20 Nuvasive, Inc. Surgical access system and related methods
US20040092992A1 (en) * 2002-10-23 2004-05-13 Kenneth Adams Disposable battery powered rotary tissue cutting instruments and methods therefor
US20040122482A1 (en) * 2002-12-20 2004-06-24 James Tung Nerve proximity method and device
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7691057B2 (en) 2003-01-16 2010-04-06 Nuvasive, Inc. Surgical access system and related methods
US7689292B2 (en) * 2003-02-27 2010-03-30 Macosta Medical U.S.A., L.L.C. Nerve stimulation functionality indicator apparatus and method
US7819801B2 (en) 2003-02-27 2010-10-26 Nuvasive, Inc. Surgical access system and related methods
US20040225228A1 (en) 2003-05-08 2004-11-11 Ferree Bret A. Neurophysiological apparatus and procedures
ES2347248T3 (en) 2003-05-30 2010-10-27 Pelikan Technologies Inc. PROCEDURE AND APPLIANCE FOR FLUID INJECTION.
US7104965B1 (en) 2003-06-06 2006-09-12 The General Hospital Corporation Interactive system and method for peripheral nerve mapping and blocking
DK1633235T3 (en) 2003-06-06 2014-08-18 Sanofi Aventis Deutschland Apparatus for sampling body fluid and detecting analyte
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
JP4436836B2 (en) 2003-08-05 2010-03-24 ヌヴァシヴ インコーポレイテッド System and method for performing dynamic pedicle integrity assessment
EP1680177B1 (en) 2003-09-25 2017-04-12 NuVasive, Inc. Surgical access system
US7905840B2 (en) 2003-10-17 2011-03-15 Nuvasive, Inc. Surgical access system and related methods
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
WO2005037095A1 (en) 2003-10-14 2005-04-28 Pelikan Technologies, Inc. Method and apparatus for a variable user interface
US8313430B1 (en) 2006-01-11 2012-11-20 Nuvasive, Inc. Surgical access system and related methods
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7555347B2 (en) * 2004-04-09 2009-06-30 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Identification of target site for implantation of a microstimulator
EP1751546A2 (en) 2004-05-20 2007-02-14 Albatros Technologies GmbH & Co. KG Printable hydrogel for biosensors
US7212865B2 (en) * 2004-05-25 2007-05-01 Philip Cory Nerve stimulator and method
WO2005120365A1 (en) 2004-06-03 2005-12-22 Pelikan Technologies, Inc. Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9622732B2 (en) 2004-10-08 2017-04-18 Nuvasive, Inc. Surgical access system and related methods
US8257356B2 (en) 2004-10-15 2012-09-04 Baxano, Inc. Guidewire exchange systems to treat spinal stenosis
JP5243034B2 (en) 2004-10-15 2013-07-24 バクサノ,インク. Tissue removal device
US9101386B2 (en) 2004-10-15 2015-08-11 Amendia, Inc. Devices and methods for treating tissue
US8048080B2 (en) 2004-10-15 2011-11-01 Baxano, Inc. Flexible tissue rasp
US7578819B2 (en) 2005-05-16 2009-08-25 Baxano, Inc. Spinal access and neural localization
US20100331883A1 (en) 2004-10-15 2010-12-30 Schmitz Gregory P Access and tissue modification systems and methods
US7857813B2 (en) 2006-08-29 2010-12-28 Baxano, Inc. Tissue access guidewire system and method
US9247952B2 (en) 2004-10-15 2016-02-02 Amendia, Inc. Devices and methods for tissue access
US7887538B2 (en) 2005-10-15 2011-02-15 Baxano, Inc. Methods and apparatus for tissue modification
US7553307B2 (en) 2004-10-15 2009-06-30 Baxano, Inc. Devices and methods for tissue modification
US7938830B2 (en) 2004-10-15 2011-05-10 Baxano, Inc. Powered tissue modification devices and methods
US8430881B2 (en) 2004-10-15 2013-04-30 Baxano, Inc. Mechanical tissue modification devices and methods
US8221397B2 (en) 2004-10-15 2012-07-17 Baxano, Inc. Devices and methods for tissue modification
US8617163B2 (en) 2004-10-15 2013-12-31 Baxano Surgical, Inc. Methods, systems and devices for carpal tunnel release
US20110190772A1 (en) * 2004-10-15 2011-08-04 Vahid Saadat Powered tissue modification devices and methods
US8062300B2 (en) 2006-05-04 2011-11-22 Baxano, Inc. Tissue removal with at least partially flexible devices
US7738969B2 (en) 2004-10-15 2010-06-15 Baxano, Inc. Devices and methods for selective surgical removal of tissue
US20060085048A1 (en) * 2004-10-20 2006-04-20 Nervonix, Inc. Algorithms for an active electrode, bioimpedance-based tissue discrimination system
WO2006044868A1 (en) * 2004-10-20 2006-04-27 Nervonix, Inc. An active electrode, bio-impedance based, tissue discrimination system and methods and use
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US7785253B1 (en) 2005-01-31 2010-08-31 Nuvasive, Inc. Surgical access system and related methods
US20060173374A1 (en) * 2005-01-31 2006-08-03 Neubardt Seth L Electrically insulated surgical probing tool
US7643884B2 (en) 2005-01-31 2010-01-05 Warsaw Orthopedic, Inc. Electrically insulated surgical needle assembly
EP2409641B1 (en) 2005-02-02 2017-07-05 NuVasive, Inc. System for performing neurophysiologic assessments during spine surgery
WO2006084194A2 (en) 2005-02-02 2006-08-10 Nuvasive, Inc. System and methods for monitoring during anterior surgery
US8092455B2 (en) 2005-02-07 2012-01-10 Warsaw Orthopedic, Inc. Device and method for operating a tool relative to bone tissue and detecting neural elements
US20110054346A1 (en) * 2005-03-01 2011-03-03 Checkpoint Surgical, Llc Systems and methods for Intra-operative semi-quantitative threshold neural response testing related applications
US20110060243A1 (en) * 2005-03-01 2011-03-10 Checkpoint Surgical, Llc Systems and methods for intra-operative regional neural stimulation
US7896815B2 (en) * 2005-03-01 2011-03-01 Checkpoint Surgical, Llc Systems and methods for intra-operative stimulation
US20060200219A1 (en) * 2005-03-01 2006-09-07 Ndi Medical, Llc Systems and methods for differentiating and/or identifying tissue regions innervated by targeted nerves for diagnostic and/or therapeutic purposes
US10154792B2 (en) 2005-03-01 2018-12-18 Checkpoint Surgical, Inc. Stimulation device adapter
US20110060242A1 (en) * 2005-03-01 2011-03-10 Checkpoint Surgical, Llc Systems and methods for intra-operative stimulation within a surgical field
US7878981B2 (en) * 2005-03-01 2011-02-01 Checkpoint Surgical, Llc Systems and methods for intra-operative stimulation
US20110060238A1 (en) * 2005-03-01 2011-03-10 Checkpoint Surgical, Llc Systems and methods for intra-operative physiological functional stimulation
US20060200023A1 (en) * 2005-03-04 2006-09-07 Sdgi Holdings, Inc. Instruments and methods for nerve monitoring in spinal surgical procedures
US20060253181A1 (en) * 2005-05-05 2006-11-09 Alfred E. Mann Foundation For Scientific Research Lead insertion tool
US8740783B2 (en) 2005-07-20 2014-06-03 Nuvasive, Inc. System and methods for performing neurophysiologic assessments with pressure monitoring
WO2007016247A2 (en) 2005-07-28 2007-02-08 Nuvasive, Inc. Total disc replacement system and related methods
US8571666B2 (en) 2005-08-02 2013-10-29 William F. Urmey Nerve stimulation system with programmed pulse charge attenuation
WO2007038290A2 (en) 2005-09-22 2007-04-05 Nuvasive, Inc. Multi-channel stimulation threshold detection algorithm for use in neurophysiology monitoring
US20070073354A1 (en) 2005-09-26 2007-03-29 Knudson Mark B Neural blocking therapy
US8568317B1 (en) 2005-09-27 2013-10-29 Nuvasive, Inc. System and methods for nerve monitoring
US8092456B2 (en) 2005-10-15 2012-01-10 Baxano, Inc. Multiple pathways for spinal nerve root decompression from a single access point
US8366712B2 (en) 2005-10-15 2013-02-05 Baxano, Inc. Multiple pathways for spinal nerve root decompression from a single access point
US8062298B2 (en) 2005-10-15 2011-11-22 Baxano, Inc. Flexible tissue removal devices and methods
US20070162051A1 (en) * 2006-01-12 2007-07-12 Alfred E. Mann Foundation For Scientific Research Electrode implant tool
US8027718B2 (en) * 2006-03-07 2011-09-27 Mayo Foundation For Medical Education And Research Regional anesthetic
US7987001B2 (en) 2007-01-25 2011-07-26 Warsaw Orthopedic, Inc. Surgical navigational and neuromonitoring instrument
US8374673B2 (en) 2007-01-25 2013-02-12 Warsaw Orthopedic, Inc. Integrated surgical navigational and neuromonitoring system having automated surgical assistance and control
WO2008124079A1 (en) * 2007-04-03 2008-10-16 Nuvasive, Inc. Neurophysiologic monitoring system
WO2008151250A1 (en) 2007-06-04 2008-12-11 I-Flow Corporation Stimulating catheter
EP2194861A1 (en) 2007-09-06 2010-06-16 Baxano, Inc. Method, system and apparatus for neural localization
US20090204173A1 (en) 2007-11-05 2009-08-13 Zi-Ping Fang Multi-Frequency Neural Treatments and Associated Systems and Methods
US8192436B2 (en) 2007-12-07 2012-06-05 Baxano, Inc. Tissue modification devices
WO2009126900A1 (en) 2008-04-11 2009-10-15 Pelikan Technologies, Inc. Method and apparatus for analyte detecting device
US7890182B2 (en) 2008-05-15 2011-02-15 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
US8398641B2 (en) 2008-07-01 2013-03-19 Baxano, Inc. Tissue modification devices and methods
US9314253B2 (en) 2008-07-01 2016-04-19 Amendia, Inc. Tissue modification devices and methods
US8409206B2 (en) 2008-07-01 2013-04-02 Baxano, Inc. Tissue modification devices and methods
EP2328489B1 (en) 2008-07-14 2019-10-09 Amendia, Inc. Tissue modification devices
ITVI20080205A1 (en) * 2008-08-29 2010-02-28 Bioampere Res Srl PERFECTED LOCALIZATION OF NERVOUS TRUNKS FOR LOCO-REGIONAL ANESTHESIA INTERVENTIONS
US8876851B1 (en) 2008-10-15 2014-11-04 Nuvasive, Inc. Systems and methods for performing spinal fusion surgery
US8255057B2 (en) 2009-01-29 2012-08-28 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US20120035730A1 (en) 2008-12-26 2012-02-09 Scott Spann Minimally-invasive retroperitoneal lateral approach for spinal surgery
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
EP2405823A4 (en) * 2009-03-13 2012-07-04 Baxano Inc Flexible neural localization devices and methods
US9351845B1 (en) 2009-04-16 2016-05-31 Nuvasive, Inc. Method and apparatus for performing spine surgery
US8287597B1 (en) 2009-04-16 2012-10-16 Nuvasive, Inc. Method and apparatus for performing spine surgery
EP2756864B1 (en) 2009-04-22 2023-03-15 Nevro Corporation Spinal cord modulation systems for inducing paresthetic and anesthetic effects
DE202010018338U1 (en) 2009-04-22 2015-10-12 Nevro Corporation Spinal cord modulation system for the relief of chronic pain
US8394102B2 (en) 2009-06-25 2013-03-12 Baxano, Inc. Surgical tools for treatment of spinal stenosis
US8498710B2 (en) 2009-07-28 2013-07-30 Nevro Corporation Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9743884B2 (en) * 2010-04-30 2017-08-29 J3G Spine, Llc Devices and methods for nerve mapping
US9392953B1 (en) 2010-09-17 2016-07-19 Nuvasive, Inc. Neurophysiologic monitoring
US9155503B2 (en) 2010-10-27 2015-10-13 Cadwell Labs Apparatus, system, and method for mapping the location of a nerve
US8649874B2 (en) 2010-11-30 2014-02-11 Nevro Corporation Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US9265897B2 (en) * 2011-01-26 2016-02-23 Avent, Inc. Method and corresponding kit for administering a paravertebral block
US8790406B1 (en) 2011-04-01 2014-07-29 William D. Smith Systems and methods for performing spine surgery
CN103987326B (en) 2011-08-19 2016-06-08 诺威适有限公司 Surgical retractor system and using method
WO2013036880A1 (en) 2011-09-08 2013-03-14 Thacker James R Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9198765B1 (en) 2011-10-31 2015-12-01 Nuvasive, Inc. Expandable spinal fusion implants and related methods
US9060815B1 (en) 2012-03-08 2015-06-23 Nuvasive, Inc. Systems and methods for performing spine surgery
US9888859B1 (en) 2013-03-14 2018-02-13 Nuvasive, Inc. Directional dilator for intraoperative monitoring
US8676331B2 (en) 2012-04-02 2014-03-18 Nevro Corporation Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US11877860B2 (en) 2012-11-06 2024-01-23 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
US11259737B2 (en) 2012-11-06 2022-03-01 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
US9757067B1 (en) 2012-11-09 2017-09-12 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring during spine surgery
US9295401B2 (en) 2012-11-27 2016-03-29 Cadwell Laboratories, Inc. Neuromonitoring systems and methods
US9757072B1 (en) 2013-02-11 2017-09-12 Nuvasive, Inc. Waveform marker placement algorithm for use in neurophysiologic monitoring
US10098585B2 (en) 2013-03-15 2018-10-16 Cadwell Laboratories, Inc. Neuromonitoring systems and methods
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
US10420480B1 (en) 2014-09-16 2019-09-24 Nuvasive, Inc. Systems and methods for performing neurophysiologic monitoring
US10463854B2 (en) 2015-02-24 2019-11-05 Elira, Inc. Systems and methods for managing symptoms associated with dysmenorrhea using an electro-dermal patch
US10433793B1 (en) 2015-03-27 2019-10-08 Cadwell Laboratories, Inc. Methods and systems for simultaneous review of brain activity and physical manifestations of users
BR112018007494B1 (en) * 2015-10-16 2022-05-03 Milestone Scientific, Inc Device for administering anesthetic fluid
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
WO2017075359A2 (en) * 2015-10-29 2017-05-04 Elira Therapeutics Llc Systems and methods for managing symptoms associated with dysmenorrhea using an electro-dermal patch
AU2017211121B2 (en) 2016-01-25 2022-02-24 Nevro Corp. Treatment of congestive heart failure with electrical stimulation, and associated systems and methods
US10799701B2 (en) 2016-03-30 2020-10-13 Nevro Corp. Systems and methods for identifying and treating patients with high-frequency electrical signals
US11446504B1 (en) 2016-05-27 2022-09-20 Nevro Corp. High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods
US11241297B2 (en) 2016-12-12 2022-02-08 Cadwell Laboratories, Inc. System and method for high density electrode management
US9935395B1 (en) 2017-01-23 2018-04-03 Cadwell Laboratories, Inc. Mass connection plate for electrical connectors
US10939867B2 (en) * 2017-03-10 2021-03-09 Robert S. Bray Paralysis monitoring system
US11517239B2 (en) 2018-04-05 2022-12-06 Cadwell Laboratories, Inc. Systems and methods for processing and displaying electromyographic signals
US11596337B2 (en) 2018-04-24 2023-03-07 Cadwell Laboratories, Inc Methods and systems for operating an intraoperative neurophysiological monitoring system in conjunction with electrocautery procedures
US11253182B2 (en) 2018-05-04 2022-02-22 Cadwell Laboratories, Inc. Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation
US11443649B2 (en) 2018-06-29 2022-09-13 Cadwell Laboratories, Inc. Neurophysiological monitoring training simulator
US11185684B2 (en) 2018-09-18 2021-11-30 Cadwell Laboratories, Inc. Minimally invasive two-dimensional grid electrode
US11517245B2 (en) 2018-10-30 2022-12-06 Cadwell Laboratories, Inc. Method and system for data synchronization
US11471087B2 (en) 2018-11-09 2022-10-18 Cadwell Laboratories, Inc. Integrity verification system for testing high channel count neuromonitoring recording equipment
US11317841B2 (en) 2018-11-14 2022-05-03 Cadwell Laboratories, Inc. Method and system for electrode verification
USD958929S1 (en) 2018-11-21 2022-07-26 Inter-Med, Inc. Minimal waste dispensing tip
US11529107B2 (en) 2018-11-27 2022-12-20 Cadwell Laboratories, Inc. Methods for automatic generation of EEG montages
US11602634B2 (en) 2019-01-17 2023-03-14 Nevro Corp. Sensory threshold adaptation for neurological therapy screening and/or electrode selection, and associated systems and methods
US11128076B2 (en) 2019-01-21 2021-09-21 Cadwell Laboratories, Inc. Connector receptacle
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313293A (en) * 1964-01-13 1967-04-11 Hewlett Packard Co Multi-electrode needle
US3682162A (en) * 1968-12-13 1972-08-08 Wellcome Found Combined electrode and hypodermic syringe needle
DE2652050A1 (en) * 1976-11-15 1978-05-24 Dieter Dr Med Theiss Electrode combination for locating neutral structures - using insulation sepd. active electrodes with superposed voltage pulses
US4291705A (en) * 1979-09-10 1981-09-29 The Regents Of The University Of California Neuromuscular block monitor
US4387723A (en) * 1980-12-09 1983-06-14 Wisconsin Alumni Research Foundation Method and apparatus for determining the level of neuromuscular block in a patient
US4515168A (en) * 1983-07-22 1985-05-07 Chester Martin H Clamp-on nerve stimulator and locator
US4563570A (en) * 1984-09-04 1986-01-07 Suncoast Medical Manufacturing, Inc. Battery powered cautery with improved protective cover arrangement
US4616660A (en) * 1984-12-10 1986-10-14 Suncoast Medical Manufacturing, Inc. Variable alternating current output nerve locator/stimulator
US4962766A (en) * 1989-07-19 1990-10-16 Herzon Garrett D Nerve locator and stimulator
US5046506A (en) * 1990-02-09 1991-09-10 Singer Medical Products, Inc. Molded needle with adhesive
US5092344A (en) * 1990-11-19 1992-03-03 Lee Tzium Shou Remote indicator for stimulator
US5284153A (en) * 1992-04-14 1994-02-08 Brigham And Women's Hospital Method for locating a nerve and for protecting nerves from injury during surgery
US5273525A (en) * 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US5306236A (en) * 1993-02-18 1994-04-26 Vickers Plc Needle electrode for use with hypodermic syringe attachment
US5549656A (en) * 1993-08-16 1996-08-27 Med Serve Group, Inc. Combination neuromuscular stimulator and electromyograph system
US5562718A (en) * 1994-06-03 1996-10-08 Palermo; Francis X. Electronic neuromuscular stimulation device
DE29517060U1 (en) * 1995-10-27 1996-02-08 Waskoenig Wilhelm Stimulation device
US5779642A (en) * 1996-01-16 1998-07-14 Nightengale; Christopher Interrogation device and method
US5853373A (en) * 1996-08-05 1998-12-29 Becton, Dickinson And Company Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures

Similar Documents

Publication Publication Date Title
MXPA97005839A (en) Two level loading impulse apparatus to facilitate nerve localization during peripheral nerve blocking procedures
AU719246B2 (en) Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures
US9056194B2 (en) Lead set for nerve stimulator and method of operation thereof
CN107427675B (en) Patient remote control and associated method for use with a neurostimulation system
EP1698373B1 (en) Systems and methods for intra-operative stimulation
US6381496B1 (en) Parameter context switching for an implanted device
US8046082B2 (en) Method and apparatus for stimulating a nerve of a patient
US8463383B2 (en) Portable assemblies, systems, and methods for providing functional or therapeutic neurostimulation
US6023642A (en) Compact transcutaneous electrical nerve stimulator
US7878981B2 (en) Systems and methods for intra-operative stimulation
JP2013525027A (en) System and method for transcutaneous electrical stimulation
KR20170047300A (en) Selective nerve fiber block method and system
JP2007516797A (en) Device to reduce pain and / or bleeding caused by injection therapy, biological tissue sampling or injury
US20210101011A1 (en) Nerve regeneration system and method
CN113348013A (en) System and method for neuroregenerative therapy
CN111511435A (en) Systems and methods for delivering neuroregenerative therapy
EP0823265A2 (en) Needle assembly for electrostimulation of a nerve
WO2014088661A1 (en) Stimulation device adapter
MXPA97005948A (en) A set of needle for electrotension of a ner
CN1177467A (en) Double-pole charge pulser convenient for positioning nerre for use in periphery nerve blocking operation
CN1177507A (en) Needle assembly for electrically stimulating nerve